Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

69 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Empagliflozin after Acute Myocardial Infarction.
Butler J, Jones WS, Udell JA, Anker SD, Petrie MC, Harrington J, Mattheus M, Zwiener I, Amir O, Bahit MC, Bauersachs J, Bayes-Genis A, Chen Y, Chopra VK, Figtree G, Ge J, Goodman SG, Gotcheva N, Goto S, Gasior T, Jamal W, Januzzi JL, Jeong MH, Lopatin Y, Lopes RD, Merkely B, Parikh PB, Parkhomenko A, Ponikowski P, Rossello X, Schou M, Simic D, Steg PG, Szachniewicz J, van der Meer P, Vinereanu D, Zieroth S, Brueckmann M, Sumin M, Bhatt DL, Hernandez AF. Butler J, et al. Among authors: zwiener i. N Engl J Med. 2024 Apr 25;390(16):1455-1466. doi: 10.1056/NEJMoa2314051. Epub 2024 Apr 6. N Engl J Med. 2024. PMID: 38587237 Clinical Trial.
Effect of Empagliflozin on Heart Failure Outcomes After Acute Myocardial Infarction: Insights From the EMPACT-MI Trial.
Hernandez AF, Udell JA, Jones WS, Anker SD, Petrie MC, Harrington J, Mattheus M, Seide S, Zwiener I, Amir O, Bahit MC, Bauersachs J, Bayes-Genis A, Chen Y, Chopra VK, A Figtree G, Ge J, G Goodman S, Gotcheva N, Goto S, Gasior T, Jamal W, Januzzi JL, Jeong MH, Lopatin Y, Lopes RD, Merkely B, Parikh PB, Parkhomenko A, Ponikowski P, Rossello X, Schou M, Simic D, Steg PG, Szachniewicz J, van der Meer P, Vinereanu D, Zieroth S, Brueckmann M, Sumin M, Bhatt DL, Butler J. Hernandez AF, et al. Among authors: zwiener i. Circulation. 2024 May 21;149(21):1627-1638. doi: 10.1161/CIRCULATIONAHA.124.069217. Epub 2024 Apr 6. Circulation. 2024. PMID: 38581389 Free PMC article. Clinical Trial.
Baseline characteristics of patients enrolled in the EMPACT-MI trial.
Harrington J, Udell JA, Jones WS, Anker SD, Bhatt DL, Petrie MC, Andersen KR, Sumin M, Zwiener I, Hernandez AF, Butler J. Harrington J, et al. Among authors: zwiener i. Eur J Heart Fail. 2023 Sep;25(9):1708-1715. doi: 10.1002/ejhf.2990. Epub 2023 Aug 25. Eur J Heart Fail. 2023. PMID: 37622416 Free article.
Empagliflozin in Heart Failure With Predicted Preserved Versus Reduced Ejection Fraction: Data From the EMPA-REG OUTCOME Trial.
Savarese G, Uijl A, Lund LH, Anker SD, Asselbergs F, Fitchett D, Inzucchi SE, Koudstaal S, Ofstad AP, Schrage B, Vedin O, Wanner C, Zannad F, Zwiener I, Butler J. Savarese G, et al. Among authors: zwiener i. J Card Fail. 2021 Aug;27(8):888-895. doi: 10.1016/j.cardfail.2021.05.012. J Card Fail. 2021. PMID: 34364665 Free article. Clinical Trial.
Effect of empagliflozin on cardiorenal outcomes and mortality according to body mass index: A subgroup analysis of the EMPA-REG OUTCOME trial with a focus on Asia.
Ji Q, Ji L, Mu Y, Zhao J, Zinman B, Wanner C, George JT, Zwiener I, Ueki K, Yokote K, Ogawa W, Johansen OE. Ji Q, et al. Among authors: zwiener i. Diabetes Obes Metab. 2021 Aug;23(8):1886-1891. doi: 10.1111/dom.14415. Epub 2021 Jun 3. Diabetes Obes Metab. 2021. PMID: 33950573 Free PMC article.
Cardio/Kidney Composite End Points: A Post Hoc Analysis of the EMPA-REG OUTCOME Trial.
Ferreira JP, Kraus BJ, Zwiener I, Lauer S, Zinman B, Fitchett DH, Koitka-Weber A, George JT, Ofstad AP, Wanner C, Zannad F. Ferreira JP, et al. Among authors: zwiener i. J Am Heart Assoc. 2021 Apr 6;10(7):e020053. doi: 10.1161/JAHA.120.020053. Epub 2021 Mar 23. J Am Heart Assoc. 2021. PMID: 33754809 Free PMC article. Clinical Trial.
Impact of polyvascular disease with and without co-existent kidney dysfunction on cardiovascular outcomes in diabetes: A post hoc analysis of EMPA-REG OUTCOME.
Verma S, Mazer CD, Inzucchi SE, Wanner C, Ofstad AP, Johansen OE, Zwiener I, George JT, Butler J, Zinman B. Verma S, et al. Among authors: zwiener i. Diabetes Obes Metab. 2021 May;23(5):1173-1181. doi: 10.1111/dom.14326. Epub 2021 Feb 24. Diabetes Obes Metab. 2021. PMID: 33502090 Free PMC article.
69 results